Substance-specific Intermediate Phenotypes
Substance Use, Use Disorders, and Recovery Core: Tier 1 Substance Use, Use Disorders, and Recovery Core: Tier 2 Assessment of Substance Use and Substance Use Disorders Substance-specific Intermediate Phenotypes Substance Use-related Neurobehavioral and Cognitive Risk Factors Substance Use-related Psychosocial Risk Factors Substance Use-related Community Factors Substance Use-related Co-morbidities and Health-related Outcomes Substance Use Recovery
| Select | Protocol | ID |
|---|---|---|
|
#520103 |
|
|
#520102 |
|
|
#520101 |
|
|
#520104 |
|
|
#520202 |
|
|
#520201 |
|
|
#520406 |
|
|
#520402 |
|
|
#520404 |
|
|
#520405 |
|
|
#520407 |
|
|
#520408 |
|
|
#520501 |
|
|
#520506 |
|
|
#520504 |
|
|
#520507 |
|
|
#520502 |
|
|
#511101 |
|
|
#520307 |
|
|
#520301 |
|
|
#520302 |
|
|
#520303 |
|
|
#520304 |
|
|
#520306 |
Release Date:
February 24, 2012; reviewed November 21, 2016
Scope of Collection
| Element Considered | Final Measures in Toolkit |
|---|---|
| Sensitivity | Acute Subjective Response to Substances - Current - General |
| Acute Subjective Response to Substances - Current - Specific - Alcohol | |
| Acute Subjective Response to Substances - Current - Specific - Drugs | |
| Acute Subjective Response to Substances - Current - Specific - Tobacco | |
| Acute Subjective Responses to Substances - Retrospective - Alcohol | |
| Acute Subjective Responses to Substances - Retrospective - Tobacco | |
| Core features of dependence | Self-reported Craving - General |
| Self-reported Craving - Specific - Alcohol | |
| Self-reported Craving - Specific - Cocaine | |
| Self-reported Craving - Specific - Heroin | |
| Self-reported Craving - Specific - Marijuana | |
| Self-reported Craving - Specific - Tobacco | |
| Cognitive processes indicative (predictive) of drug dependence | Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Alcohol |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Illegal Stimulant Drugs | |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Marijuana | |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Prescription Stimulant Drugs | |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Tobacco | |
| Motives - Alcohol, Tobacco and Other Substances - General | |
| Motives - Alcohol, Tobacco and Other Substances - Specific - Drugs | |
| Motives - Alcohol, Tobacco and Other Substances - Specific - Tobacco | |
| Motives - Alcohol, Tobacco, and Other Substances - Specific - Alcohol |
Working Group Roster:
WG Members:
|
Harriet de Wit, PhD, Co-Chair University of Chicago Chicago, IL |
Stephanie S. O'Malley, PhD, Co-Chair Yale University Department of Psychology New Haven, CT |
|
Kathleen Bucholz, PhD Washington University in St. Louis St. Louis, MO |
Dan Falk, PhD National Institute on Alcohol Abuse and Alcoholism (NIAAA) Bethesda, MD |
|
Hank Kranzler, MD University of Pennsylvania Philadelphia, PA |
Kenzie Preston, PhD National Institute on Drug Abuse (NIDA) NIDA Intramural Research Program Rockville, MD |
|
Ken Winters, PhD University of Minnesota, Twin Cities Minneapolis, MN |
Substance Use, Use Disorders, and Recovery Panel Liaison, WG Manager and WG Supervisor:
|
Arpana Agrawal, PhD, SAA Scientific Panel Liaison Washington University in St. Louis St. Louis, MO |
Kevin P. Conway, PhD, SAA Scientific Panel Liaison National Institute on Drug Abuse (NIDA) Division of Epidemiology, Services, and Prevention Research Rockville, MD |
|
Dana B. Hancock, PhD, WG Supervisor RTI International Research Triangle Park, NC |
Michael Phillips, MS, WG Manager RTI International Research Triangle Park, NC |
Substance Use and Recovery:
WG Members:
|
Anne Buu, PhD University of Texas Health Science Center at Houston Houston, TX |
John Kelly, PhD Harvard Medical School Boston, MA |
|
Amanda Bunting, PhD NY Langone Medical Center New York, NY |
Denise Vidot, PhD University of Miami Miami, FL |
|
Christian Hopfer, MD University of Colorado, Denver Denver, CO |
Corrie Vilsaint, PhD MGH Recovery Research Institute Boston, MA |
|
Ryan McNeil, PhD Yale University New Haven, CT |
Sarah Zemore, PhD Alcohol Research Group Emeryville, CA |
|
Johannes Thrul, PhD Johns Hopkins University Baltimore, MD |
Substance Use and Recovery Panel Liaison, WG Manager and WG Supervisor:
|
Cataia Ives, MS RTI International Research Triangle Park, NC |
Tamara Haegerich, PhD National Institute on Drug Abuse (NIDA) Rockville, MD |
|
Christine Hill, MPA RTI International Atlanta, GA |
Jyoti Dayal, MS National Human Genome Research Institute (NHGRI) Bethesda, MD |
Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.
Substance-specific Intermediate Phenotypes Supplemental Information includes:Additional Information:
There is no additional information for this collection.